-
Tue28Jan2025Thu30Jan2025
-
Thu13Feb2025Sat15Feb2025
-
Thu20Feb2025Sat22Feb2025
-
Sun09Mar2025Tue11Mar2025
-
Sun16Mar2025Tue18Mar2025
-
Sat29Mar2025Thu03Apr2025
-
Thu03Apr2025Fri04Apr2025
-
Wed23Apr2025Fri25Apr2025
Latest News
US FDA approves Humacyte’s Symvess for vascular trauma
Humacyte recently shared that the US Food and Drug Administration (FDA) has granted a full approval for the Symvess acellular tissue-engineered vessel.
A press release...
Features
Vascular News’ top 10 most popular stories of November 2024
Late-breaking data shared at VIVA 2024 (3–6 November, Las Vegas, USA), the first-in-human implantation of a new bridging stent, and an interview with Ramon Varcoe...
Q&A: The SUNDAY trial
Tim Resch (University of Copenhagen, Copenhagen, Denmark) gives an update on the SUNDAY trial, which is set to provide some much-needed data on treatment...
Videos
The six-month results of the WAVE (WRAPSODY Arteriovenous Access Efficacy) pivotal trial have reported superior target lesion primary patency (TLPP) with the WRAPSODY (Merit Medical) cell-impermeable endoprosthesis when compared to percutaneous transluminal angioplasty (PTA) when used in failing arteriovenous...
